BRCA2 and endometrial cancer: In the meta-analysis by Lee et al. [32], the endometrial cancer risk was marginally increased for BRCA1/2 GPV carriers and/or [un]tested family members [RR 1.53, 95% CI 1.01–2.31 for BRCA1 and RR 1.48, 95%CI 1.24–1.78 for BRCA2].